Arvee Laboratories (India) Ltd.

ARVEE

INE006Z01016

Diversified Chemicals

Market Closed - NSE India S.E. Other stock markets 07:43:53 2024-06-28 am EDT			5-day change	1st Jan Change
192.2 ^INR	+0.90%		-0.25%	+11.13%

May. 17	Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
Mar. 26	Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director	CI

Arvee Laboratories Ltd. Approves Appointment of Mr. Paragbhai Manubhai Shah as Independent Director

June 27, 2020 at 09:07 am EDT

Arvee Laboratories (India) Ltd. announced that the Board of Directors of the Company in their meeting on 27 June, 2020, have approved the appointment of Mr. Paragbhai Manubhai Shah as Independent Director of the Company with immediate effect.

Latest news about Arvee Laboratories (India) Ltd.

Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 17	CI
Arvee Laboratories Ltd. Announces Resignation of Mr. Dipen Dalal as Independent Director	Mar. 26	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 07	CI
Arvee Laboratories Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-05	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-11	CI
Arvee Laboratories Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-02	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-26	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-26	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-08	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Arvee Laboratories Ltd. Announces Demise of Parag Manubhai Shah, Independent Director	21-09-17	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2021	21-07-17	CI
Arvee Laboratories Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-17	CI
1,130,000 Equity Shares of Arvee Laboratories Limited are subject to a Lock-Up Agreement Ending on 27-FEB-2021.	21-02-26	CI
Arvee Laboratories Ltd. Appoints Neetu Jalan as a Non-Executive Independent Director	21-02-12	CI
Arvee Laboratories Ltd. Announces Unaudited Earnings Results for the Half Year Ended September 30, 2020	20-12-07	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the Full Year Ended March 31, 2020	20-06-29	CI
Arvee Laboratories Ltd. Approves Appointment of Mr. Paragbhai Manubhai Shah as Independent Director	20-06-27	CI
Arvee Laboratories India Ltd. Reports Earnings Results for the Half Year Ended September 30, 2019	19-11-13	CI
2,920,000 Equity Shares of Arvee Laboratories Limited are subject to a Lock-Up Agreement Ending on 27-FEB-2019.	19-02-26	CI
Arvee Laboratories Limited has completed an IPO in the amount of INR 89.06 million.	18-02-21	CI
Arvee Laboratories Limited has filed an IPO in the amount of INR 89.06 million.	17-12-21	CI

Chart Arvee Laboratories (India) Ltd.

Duration

Period

More charts

Company Profile

Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.

Sector

Diversified Chemicals

Calendar

2024-07-29 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diversified Chemicals

	1st Jan change	Capi.
ARVEE LABORATORIES (INDIA) LTD.	+11.13%	25.15M
SHIN-ETSU CHEMICAL CO., LTD.	+5.43%	76.68B
BASF SE	-7.37%	43.33B
DUPONT DE NEMOURS, INC.	+4.63%	33.44B
PIDILITE INDUSTRIES LIMITED	+16.35%	19.16B
EASTMAN CHEMICAL COMPANY	+9.07%	11.43B
BRENNTAG SE	-24.35%	9.82B
SYENSQO SA/NV	-11.34%	9.75B
ASAHI KASEI CORPORATION	-0.82%	8.91B
SRF LIMITED	-1.92%	8.73B